Company Profile
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Latest News

Tactile Systems Technology (TCMD) Q2 2026 Earnings Call Transcript
Tactile Systems Technology Insider Sold Shares Worth $323,243, According to a Recent SEC Filing
Sector Update: Healthcare Stocks Softer Late Afternoon
Sector Update: Healthcare
Tactile Systems Technology Shares Fall After Q2 Results, Lowered 2026 Revenue Guidance

Tactile Systems Technology, Inc. Q2 2026 Earnings Call Summary
Related stocks
Key Metrics & Overview
Detailed metrics & financial data of the company
🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data